CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
GLIOTRAIN focuses on developing new treatment strategies for glioblastoma, a deadly brain tumor. The project trains researchers in advanced techniques like next-generation sequencing and multi-omics to better understand and combat the disease.
Glioblastoma (GBM) is the most frequent, aggressive and lethal of all brain tumours.
It has a universally fatal prognosis with 85% of patients dying within two years.
New treatment options and effective precision medicine therapies are urgently required.
This can only be achieved by focused multi-sectoral industry-academia collaborations in newly emerging, innovative research disciplines. GLIOTRAIN will exploit the intractability of GBM to address European applied biomedical research training ne…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Stuttgart
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
VLAAMS INSTITUUT BIOTECHNOLOGIE FLANDERS INSTITUTE FOR BIOTECHNOLOGY
Belgium, ZWIJNAARDE - GENT
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
